AusPAR: Maviret

Australian Public Assessment Report

AusPAR

AusPAR: Maviret [PDF, 870.62 KB]

AusPAR: Maviret [Word, 1.34 MB]

AusPAR Attachment 1: Product Information for Maviret [PDF, 457.44 KB]

AusPAR Attachment 1: Product Information for Maviret [Word, 128.06 KB]

Device/Product Name

Maviret

Active ingredients

Glecaprevir and pibrentasvir

AusPAR Date

20 February 2023

Published

6 March 2023

Submission Number

PM-2020-06602-1-2

Submission Type

Major variation and extension of indication

Decision

Approved